Model Number 3CX*FX15RW40C |
Device Problem
Infusion or Flow Problem (2964)
|
Patient Problems
Death (1802); No Consequences Or Impact To Patient (2199)
|
Event Date 08/27/2020 |
Event Type
Death
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, they noticed drop of oxygenation.Per user facility the patients came in with severe respiratory infection.His lvad malfunctioned and it seemed blocked so they replaced it with another.They went on bypass at 14.21 h.Oxygenation drop at 14.57 pm co2 41 /po2 78 change out oxygenator at 14.58pm at full flow 257 po2.Finished case at 16.07 pm pco2 =21, po2=251 see connect file for all data.No consequences or impact to patient.Product was changed out.Procedure was completed successfully.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on september 16, 2020.Upon further investigation of the reported event, the following information is new and/or changed: describe event or problem - added new information).(device availability - added date returned to manufacturer).(date received by manufacturer).(indication that this is a follow-up report).(type of reportable event - added new information).(follow-up due to additional information).(device evaluation anticipated by manufacturer - a second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references.) (event problem and evaluation codes - patient code).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Event Description
|
New information was received indicating that on (b)(6) 2020 the patient passed away from septic shock.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: (additional device information - added expiration date).(date received by manufacturer).(indication that this is a follow-up report).(follow-up due to additional information and device evaluation).(device evaluated by manufacturer).(device manufacture date).Visual inspection of the sample found no obvious anomaly that could lead to poor gas transfer performance.After having been rinsed and dried, it was tested for its gas transfer performance and found no anomalies and meet the factory specification.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|